Canada's top court hands patent win to pharmaceutical companies

OTTAWA (Reuters) - Canada's Supreme Court on Friday struck down rules making it easy for generic drug firms to overturn patents granted to pharmaceutical companies, a decision that removes an irritant in the run-up to talks on NAFTA.